Skip to main content

Provider

By HIMSS TV | 08:10 am | October 12, 2020
HealthShare Exchange President and CEO Martin Lupinetti discusses lessons learned about data quality and reaching seniors during the COVID-19 crisis.
By Sara Mageit | 02:36 am | October 10, 2020
In recognition of World Mental Health Day today, MobiHealthNews explores the ways the acceleration of mental health tech such as VR, mood wearables and AI in recent months has significantly changed the way we use and look at mental health therapy. 
By MobiHealthNews | 12:42 pm | October 09, 2020
Bradley Merrill Thompson, an FDA-watcher, lawyer and occasional MobiHealthNews guest contributor, joins the MobiHealthNews team for a closer look at what the FDA has been up to around digital health and AI.
By HIMSS TV | 12:30 pm | October 09, 2020
This week's top stories include HHS requiring hospitals to report flu data, Americans wanting mental healthcare via telehealth, and Clover Health joining the public market by merging with Social Capital SPAC.
By Sara Mageit | 04:42 am | October 09, 2020
Also, InHealthcare and Olympus help the NHS expand diagnostic capacity.
By Dave Muoio | 03:43 pm | October 08, 2020
The novel approach could help public health authorities focus their contact tracing and quarantine efforts on those at greater risk of infection.
By HIMSS TV | 03:34 pm | October 08, 2020
Liz Ashall-Payne, founder and CEO of ORCHA, says COVID-19 has accelerated the adoption of telehealth, but digital therapeutics, diagnostics and remote patient monitoring will play a more significant role moving forward.
By Mallory Hackett | 01:46 pm | October 08, 2020
Participants reported being more confident and had improved self-efficacy to stop smoking after completing the preliminary intervention.
By HIMSS TV | 08:19 am | October 08, 2020
Telehealth Connection TV: Howard University College of Medicine's Michael Crawford discusses what the 1867 Health Innovations Project is finding out about virtual care and telemedicine.
By Sara Mageit | 08:05 am | October 08, 2020
The capital raised will also increase its team of clinical trial experts in serving both pharma and patients across the UK and overseas.